SLC2A9 p.Val282Ile

Variant summary

Our verdict is Likely benign.
-5 Likely Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -5 classification points (ACGS-UK Somatic Oncogenicity v2025). B1_StrongB3_Supporting

The NM_020041.3(SLC2A9):c.844G>A (p.Val282Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The gene SLC2A9 is a tumor suppressor gene (CancerMine: 2 TSG citations). The variant allele was found at a cumulative frequency of 0.229 (AC=370,036) in the gnomAD database across 1,613,968 control chromosomes, including 46,504 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.429. In-silico predictor (REVEL) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign/Likely Benign (★★). The variant has been observed in cBioPortal in 4 samples across 3 studies and 3 cancer types; somatic enrichment level: SUPPORTING_LOW (Observed in a small number of cBioPortal cases.). This exact variant is curated in the UniProt human variants database as Uncertain Significance; it is also listed as a COSMIC curated somatic variant.

Frequency

Genomes: 𝑓 0.28 ( 6967 hom., cov: 33)
Exomes 𝑓: 0.22 ( 39537 hom. )

Consequence

SLC2A9
NM_020041.3 missense

Scores

2
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 1.76

Publications

147 publications found
Variant links:
Genes affected
SLC2A9 (HGNC:13446): (solute carrier family 2 member 9) This gene encodes a member of the SLC2A facilitative glucose transporter family. Members of this family play a significant role in maintaining glucose homeostasis. The encoded protein may play a role in the development and survival of chondrocytes in cartilage matrices. Two transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
SLC2A9 Gene-Disease associations (from GenCC):
  • hypouricemia, renal, 2
    Inheritance: AR, AD, SD Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
  • hereditary renal hypouricemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_020041.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Likely_benign. The variant received -5 points.

B1High frequency in general population
GnomAD effective popmax AF >1% — B1 stand-alone benign; GnomAD effective popmax AF = 0.429 — exceeds 1% threshold (B1 applied)
B3Computational evidence does not support deleterious effect
Computational evidence does not support a deleterious effect; Missense variant — primary computational scorer does not support an oncogenic/deleterious effect; supports B3

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_020041.3. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

SLC2A9 NM_020041.3
MANE Select
HGVSc / HGVSpc.844G>Ap.Val282Ile
Exon rankExon 7 of 12
missense
Prot: NP_064425.2
SLC2A9 NM_001001290.2
HGVSc / HGVSpc.757G>Ap.Val253Ile
Exon rankExon 8 of 13
missense
Prot: NP_001001290.1UniProt: Q9NRM0-2

Ensembl Transcripts

SLC2A9 ENST00000264784.8
TSL:1MANE Select
HGVSc / HGVSpc.844G>Ap.Val282Ile
Exon rankExon 7 of 12
missense
Prot: ENSP00000264784.3UniProt: Q9NRM0-1
SLC2A9 ENST00000309065.7
TSL:1
HGVSc / HGVSpc.757G>Ap.Val253Ile
Exon rankExon 8 of 13
missense
Prot: ENSP00000311383.3UniProt: Q9NRM0-2
SLC2A9 ENST00000505104.5
TSL:1
HGVSc / HGVSpn.878G>A
Exon rankExon 8 of 12
non_coding_transcript_exon
Prot:

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 6 sources
GnomAD3 genomes
AF: 0.282
AC:42936
Hom:6956
AN:152072
Cov:33
GnomAD2 exomes
AF: 0.243
AC:61149
AN:251162
GnomAD4 exome
AF: 0.224
AC:327053
Hom:39537
AN:1461778
Cov:38
GnomAD4 genome
AF: 0.282
AC:42983
Hom:6967
AN:152190
Cov:33
TOPMed (Bravo)
AF: 0.300
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.248
AC:83850
Hom:11588
AN:338330
Local & regional cohorts 11 sources
ABraOM SABE-WGS-1171
AF: 0.289
AC:677
Hom:106
AN:2342
ChinaMAP Phase 1
AF: 0.0193
Denmark Genome
AF: 0.233
AC:70
AN:300
ESP6500 (Exome Variant Server)
AF: 0.286
AC:3724
AN:13006
GenomeAsia100K
AF: 0.153
AC:532
AN:3478
Korea4K (4,157 Koreans)
AF: 0.0100
AC:73
AN:7234
Qatari Genome
AF: 0.218
AC:438
AN:2010
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.00847
AC:1039
Hom:6
AN:122716
Turkish Variome
AF: 0.270
AC:1804
Hom:273
AN:6670
UK10K
AF: 0.218
AC:1646
AN:7562
WBBC (Westlake BioBank for Chinese) pilot
AF: 0.0126
AC:113
Hom:1
AN:8960
Showing 17 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
ASC
(Autism)
0.210 *233311106 0.208 *365417598
BipEx
(Bipolar disorder (including schizoaffective))
0.209 595028420 0.211 608728844
Epi25
(Epilepsy)
0.221 928841958 0.243 1628666886
SCHEMA
(Schizophrenia)
0.201 24261120558 0.206 38834188774
Showing 4 cohortsAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
2
Hypouricemia, renal, 2 (2)
-
-
1
not specified (1)

Computational Scores

AlphaGenome AVI
Benign9.3
AlphaMissense
Benign0.17
BayesDel_addAF
Benign-0.64T
BayesDel_noAF
Benign-0.55
CADD
Benign4.5
DANN
Benign0.95
DEOGEN2
Benign0.10T
Eigen
Benign-0.58
Eigen_PC
Benign-0.64
FATHMM_MKL
Uncertain0.88D
FuncVEP CTI
Benign0.14
GPN-Star LLR
N/A-1.3
GPN-Star score
N/A1.3
LIST_S2
Benign0.72T
MetaRNN
Benign0.028T
MetaSVM
Benign-0.98T
Mutation Taster
N/A100/0polymorphism (auto)
MutationAssessor
Uncertain2.1M
PhyloP100
Benign1.8
popEVE
Benign-3.0
PrimateAI
Benign0.30T
PROVEAN
Benign-0.47N
RBP_binding_hub_radar
N/A0.0
RBP_regulation_power_radar
N/A1.1
REVEL
Benign0.23
Sift
Benign0.16T
Sift4G
Benign0.25T
Varity_R
N/A0.052
VESM-3B
Benign-5.8
Showing 29 of 29 scores

Splicing Scores

Pangolin (max)
Benign0.010
SpliceAI score (max)
Benign0.020
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

dbSNP: rs16890979;
hg19: chr4-9922167;
COSMIC: COSV53316809;
COSMIC: COSV53316809;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.